RaQualia Pharma Inc. (TYO:4579)

Japan · Delayed Price · Currency is JPY

899.00

+12.00 (1.35%)

Mar 6, 2026, 3:30 PM JST

Revenue by Segment

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2014
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '14 Dec 31, 2014
Research and Development of Pharmaceutical and Related Businesses	3.98B	3.11B	1.90B	2.92B	2.78B
Research and Development of Pharmaceutical and Related Businesses Growth	28.10%	63.44%	-34.85%	5.12%	150.77%
Total	3.98B	3.11B	1.90B	2.92B	2.78B
Total Growth	28.10%	63.44%	-34.85%	5.12%	150.77%

Revenue by Geography

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2014
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '14 Dec 31, 2014
Japan	710.93M	6.11M	741.66M	1.19B
Japan Growth	11533.58%	-99.18%	-37.53%	4175.61%
Asia	1.26B	800.80M	1.03B	584.83M
Asia Growth	56.79%	-22.55%	76.80%	10.33%
Others	12.26M	3.51M	-	-
Others Growth	249.53%	-	-	-
United States of America	1.13B	1.09B	1.14B	1.00B
United States of America Growth	3.49%	-4.52%	13.77%	82.74%
Total	3.11B	1.90B	2.92B	2.78B
Total Growth	63.45%	-34.85%	5.11%	150.72%

Source: S&P Global Market Intelligence.